MPO and infection: Among MGAS5005-infected mice, the total MPO activity at MGAS5005 infection sites of SseM1-immunized mice (61.18 ± 6.75 U) was 3.3-fold higher than that of control mice (18.67 ± 5.73 U) (P = 0.0012) (Figure 3C).